Search details
1.
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Jpn J Clin Oncol
; 54(4): 424-433, 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38251744
2.
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
Jpn J Clin Oncol
; 54(4): 489-497, 2024 Apr 06.
Article
in English
| MEDLINE | ID: mdl-38157885
3.
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study.
Int J Clin Oncol
; 28(10): 1411-1420, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37526805
4.
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor.
Int J Mol Sci
; 24(3)2023 Jan 19.
Article
in English
| MEDLINE | ID: mdl-36768352
5.
Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cells.
Carcinogenesis
; 43(7): 647-658, 2022 08 30.
Article
in English
| MEDLINE | ID: mdl-35353883
6.
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis.
Int J Clin Oncol
; 27(8): 1247-1255, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35612720
7.
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
Int J Clin Oncol
; 27(12): 1874-1880, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36214925
8.
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis.
Gynecol Oncol
; 162(2): 292-298, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34016453
9.
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model.
Int J Clin Oncol
; 26(3): 591-597, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33146805
10.
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer.
Medicina (Kaunas)
; 57(5)2021 May 15.
Article
in English
| MEDLINE | ID: mdl-34063455
11.
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
Medicina (Kaunas)
; 57(6)2021 May 29.
Article
in English
| MEDLINE | ID: mdl-34072478
12.
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions.
Int J Mol Sci
; 21(7)2020 Mar 27.
Article
in English
| MEDLINE | ID: mdl-32230938
13.
Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides.
Scand J Immunol
; : e12698, 2018 Jun 23.
Article
in English
| MEDLINE | ID: mdl-29935085
14.
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations.
Invest New Drugs
; 35(6): 800-812, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28864978
15.
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
Int J Clin Oncol
; 21(4): 735-740, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-26782958
16.
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Int J Clin Oncol
; 21(6): 1120-1127, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27342833
17.
Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy.
Int J Clin Oncol
; 20(2): 345-50, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-24825458
18.
Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancer.
Int J Gynecol Cancer
; 24(6): 1093-7, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24978712
19.
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix.
Int J Clin Oncol
; 19(2): 336-40, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-23494222
20.
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study.
Int J Clin Oncol
; 19(6): 1052-8, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24395448